Professor Anstee first joined Newcastle University in 2010, returning to his native North East from London where he had trained at UCL and received his PhD from Imperial. He then completed his specialist training whilst working as a Clinical Lecturer in Medicine & Hepatology.

His translational and clinical research has extended from the bench to the bedside, with particular focus on the pathogenesis, diagnosis and treatment of Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD). Currently he is Dean of Research & Innovation, and the Ruth & Lionel Jacobson Chair of Personalised Medicine, which recognises his strong track record of working in medical science and across disciplines.

A practising clinician, Professor Anstee is also an NIHR Senior Investigator and has been named as one of the world’s most influential researchers in the Web of Science list of Highly Cited Researchers, amongst the top 1% of scientists by citation metrics.

As PVC FMS, Quentin will play a pivotal role in the strategic development and operation of education and research within the faculty, delivering both the University and Faculty Strategic goals. He will also play a key role in developing and fostering regional partnerships with key partners such as the NHS and other institutions to develop mutually beneficial opportunities.

'Fostering regional partnerships'

As PVC FMS, Quentin will play a pivotal role in the strategic development and operation of education and research within the faculty, delivering both the University and Faculty Strategic goals. He will also play a key role in developing and fostering regional partnerships with key partners such as the NHS and other institutions to develop mutually beneficial opportunities.

Professor Anstee said of his appointment: “I am deeply honoured to take on the role of Pro Vice-Chancellor of the Faculty of Medical Sciences.  As a native of the North-East and a member of the university for 15 years, our tradition of excellence in medical education, research, and clinical impact is a source of immense pride. These are challenging times for UK higher education, but they also present opportunities. I look forward to working with colleagues across the university, our students, and our partners in the NHS and across the region to build on this legacy.”

Professor Chris Day, Vice-Chancellor and President at Newcastle University said: “I am delighted to have Quentin join our Executive Board team.  At a time when we are facing so much change within our University and the sector itself it is really positive to have someone who will work closely with colleagues and teams across the University and the region to further develop our strengths in the Faculty of Medical Sciences. As a highly respected clinician and academic, he will further enhance our track record of taking our discovery research into the clinic.”

Professor Anstee will take up the position from 1 August 2025.